LeonaBio, Inc. (LONA)
4.62
-0.15
(-3.14%)
USD |
NASDAQ |
Nov 04, 14:58
LeonaBio Price to Book Value : 1.296 for Nov. 4, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 03, 2026 | 1.338 |
| November 02, 2026 | 1.326 |
| October 30, 2026 | 1.385 |
| October 29, 2026 | 1.377 |
| October 28, 2026 | 1.391 |
| October 27, 2026 | 1.371 |
| October 26, 2026 | 1.335 |
| October 23, 2026 | 1.357 |
| October 22, 2026 | 1.394 |
| October 21, 2026 | 1.590 |
| October 20, 2026 | 1.478 |
| October 19, 2026 | 1.416 |
| October 16, 2026 | 1.458 |
| October 15, 2026 | 1.484 |
| October 14, 2026 | 1.512 |
| October 13, 2026 | 1.803 |
| October 12, 2026 | 1.729 |
| October 09, 2026 | 1.613 |
| October 08, 2026 | 1.613 |
| October 07, 2026 | 1.635 |
| October 06, 2026 | 1.613 |
| October 05, 2026 | 1.565 |
| October 02, 2026 | 1.352 |
| October 01, 2026 | 1.228 |
| September 30, 2026 | 1.001 |
| Date | Value |
|---|---|
| September 29, 2026 | 0.9844 |
| September 28, 2026 | 0.8049 |
| September 25, 2026 | 0.9115 |
| September 24, 2026 | 1.399 |
| September 23, 2026 | 1.652 |
| September 22, 2026 | 1.697 |
| September 21, 2026 | 1.775 |
| September 18, 2026 | 1.904 |
| September 17, 2026 | 1.949 |
| September 16, 2026 | 1.904 |
| September 15, 2026 | 2.030 |
| September 14, 2026 | 2.095 |
| September 11, 2026 | 1.941 |
| September 10, 2026 | 1.924 |
| September 09, 2026 | 1.974 |
| September 08, 2026 | 2.249 |
| September 04, 2026 | 2.120 |
| September 03, 2026 | 2.160 |
| September 02, 2026 | 2.151 |
| September 01, 2026 | 2.129 |
| August 31, 2026 | 2.221 |
| August 28, 2026 | 2.227 |
| August 27, 2026 | 2.213 |
| August 26, 2026 | 2.190 |
| August 25, 2026 | 2.246 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Cocrystal Pharma, Inc. | 13.47 |
| CNBX Pharmaceuticals, Inc. | -- |
| Arvinas, Inc. | 0.9408 |
| Fulcrum Therapeutics, Inc. | 0.9232 |
| Definium Therapeutics, Inc. | 4.765 |
Price to Book Value Related Metrics
| PEG Ratio | -0.0008 |
| Price | 4.62 |
| Earnings Yield | -500.2% |
| Market Cap | 43.53M |
| PEGY Ratio | -0.0008 |